| 英文名稱 |
中文名稱 |
CAS號 |
操作 |
| SRT 1720 |
N-[2-[3-(1-哌嗪基甲基)咪唑并[2,1-B]噻唑-6-基]苯基]-2-喹喔啉甲酰胺 |
925434-55-5 |
詳細(xì)
|
| Benzenepentanol, α-[2-(4-hydroxy-3-methoxyphenyl)ethyl]- |
益智醇 |
87657-77-0 |
詳細(xì)
|
| Mitoquinone mesylate |
米托蒽醌甲磺酸鹽 |
845959-50-4 |
詳細(xì)
|
| 2',3'-cGAMP sodium salt |
2,3-CGAMP |
1441190-66-4 |
詳細(xì)
|
| 2'-Deoxyguanosine monohydrate |
2'-脫氧鳥苷一水 |
312693-72-4 |
詳細(xì)
|
| DiMNF |
3',4'-DiMethoxy-α-naphthoflavone |
14756-24-2 |
詳細(xì)
|
| AIM-100 |
5,6-二苯基-N-[[(2S)-四氫-2-呋喃基]甲基]呋喃并[2,3-D]嘧啶-4-胺 |
873305-35-2 |
詳細(xì)
|
| AN-3485 |
AN-3485 |
1213827-99-6 |
詳細(xì)
|
| Anifrolumab |
Anifrolumab |
1326232-46-5 |
詳細(xì)
|
| Benpyrine |
BENPYRINE |
2550398-89-3 |
詳細(xì)
|
| BLZ-945 |
BLZ945 |
953769-46-5 |
詳細(xì)
|
| 2-AMINO-5-BROMO-4-HYDROXY-6-PHENYLPYRIMIDINE |
溴匹立明 |
56741-95-8 |
詳細(xì)
|
| C 87 |
332420-90-3 |
332420-90-3 |
詳細(xì)
|
| Calmidazolium chloride |
鈣調(diào)蛋白抑制劑 |
57265-65-3 |
詳細(xì)
|
| 4-HYDROXY-3-METHOXYCINNAMALDEHYDE |
松柏醛 |
458-36-6 |
詳細(xì)
|
| CL075 |
2-丙基噻唑并[4,5-C]喹啉-4-胺 |
256922-53-9 |
詳細(xì)
|
| CL097 |
化合物CL097 |
1026249-18-2 |
詳細(xì)
|
| Danicopan |
Danicopan |
1903768-17-1 |
詳細(xì)
|
| DCC3014 |
DCC3014 |
1628606-05-2 |
詳細(xì)
|
| DDR Inhibitor |
1644069-80-6 |
1644069-80-6 |
詳細(xì)
|
| DDR1-IN-1 |
N-[3-[(2,3-二氫-2-氧代-1H-吲哚-5-基)氧基]-4-甲基苯基]-4-[(4-乙基-1-哌嗪基)甲基]-3-(三氟甲基)苯甲酰胺 |
1449685-96-4 |
詳細(xì)
|
| Disitertide |
地司特泰 |
272105-42-7 |
詳細(xì)
|
| DSHS00884 |
DSHS00884 |
675104-49-1 |
詳細(xì)
|
| DSR-6434 |
DSR 6434 |
1059070-10-8 |
詳細(xì)
|
| Etanercept |
依那西普 |
185243-69-0 |
詳細(xì)
|
| Evatanepag |
2-[3-[N-(4-叔丁基芐基)-N-(吡啶-3-基磺酰基)氨基甲基]苯氧基]乙酸 |
223488-57-1 |
詳細(xì)
|
| FSL-1 |
FSL-1 lipoprotein, synthetic |
322455-70-9 |
詳細(xì)
|
| GW-2580 |
GW2580 |
870483-87-7 |
詳細(xì)
|
| GW-4064 |
3-(2,6-二氯苯基)-4-(3'-羧基-2-氯二苯乙烯-4-基)氧甲基-5-異丙基異惡唑 |
278779-30-9 |
詳細(xì)
|
| GW-441756 |
GW441756 |
504433-23-2 |
詳細(xì)
|
| GW-788388 |
GW788388 |
452342-67-5 |
詳細(xì)
|
| Gardiquimod |
4-氨基-2-[(乙基氨基)甲基]-ALPHA,ALPHA-二甲基-1H-咪唑并[4,5-C]喹啉-1-乙醇 |
1020412-43-4 |
詳細(xì)
|
| GB1107 |
GB1107 |
1978336-61-6 |
詳細(xì)
|
| GNF351 |
GNF351 |
1227634-69-6 |
詳細(xì)
|
| PR-619 |
2,6-二氨基-3,5-二硫氰基吡啶 |
2645-32-1 |
詳細(xì)
|
| JTV-519 hemifumarate |
JTV-519 HEMIFUMARATE |
1435938-25-2 |
詳細(xì)
|
| Voclosporin |
伏環(huán)孢素 |
515814-01-4 |
詳細(xì)
|
| ZYZ-488 |
ZYZ-488 |
1470302-79-4 |
詳細(xì)
|
| LANATOSIDE C |
毛花苷 C |
17575-22-3 |
詳細(xì)
|
| L-KAWAIN |
醉椒素 |
500-64-1 |
詳細(xì)
|
| NQTrp |
N-(1,4-Dihydro-1,4-dioxo-2-naphthalenyl)-L-tryptophan |
185351-19-3 |
詳細(xì)
|
| IWP-2 |
IWP-2 |
686770-61-6 |
詳細(xì)
|
| J-147 |
J-147 |
1146963-51-0 |
詳細(xì)
|
| JNJ-0966 |
JNJ0966 |
315705-75-0 |
詳細(xì)
|
| KB-NB77-78 |
9-(TERT-BUTYLDIMETHYLSILYLOXY)-3,4-DIHYDRO-1H-CHROMENO[3,4-B]PYRIDIN-5(2H)-ONE |
1350622-33-1 |
詳細(xì)
|
| K-02288 |
K02288 |
1431985-92-0 |
詳細(xì)
|
| JNJ-31020028 |
JNJ 31020028 |
1094873-14-9 |
詳細(xì)
|
| LANOSTEROL |
羊毛甾醇 |
79-63-0 |
詳細(xì)
|
| (R)-1-(2-(2,5-dichlorobenzamido)acetamido)-3-methylbutylboronic acid |
埃沙左米 |
1072833-77-2 |
詳細(xì)
|
| IWP-L6 |
IWP-L6 |
1427782-89-5 |
詳細(xì)
|
| OAC-1 |
N-1H-吡咯并[2,3-C]吡啶-5-基苯甲酰胺 |
300586-90-7 |
詳細(xì)
|
| OAC-2 |
OAC2 |
6019-39-2 |
詳細(xì)
|
| LDC-1267 |
LDC1267 |
1361030-48-9 |
詳細(xì)
|
| Tolimidone |
托利咪酮 |
41964-07-2 |
詳細(xì)
|
| Methotrexate metabolite |
DAMPA |
19741-14-1 |
詳細(xì)
|
| NSC 116966 |
ESI-05 |
5184-64-5 |
詳細(xì)
|
| NSC 117079 |
化合物 T12260 |
500363-63-3 |
詳細(xì)
|
| (10-METHYL-9-ANTHRACENYL) CARBAMIMIDOTHIOIC ACID METHYL ESTER HYDROCHLORIDE |
NSC 146109鹽酸鹽 |
59474-01-0 |
詳細(xì)
|
| NSC 150117 |
Dual Specificity Protein Phosphatase 1/6 Inhibitor |
15982-84-0 |
詳細(xì)
|
| NSC 16168 |
4-amino-5-(tosyloxy)naphthalene-2,7-disulfonic acid |
6837-93-0 |
詳細(xì)
|
| NSC 185058 |
N-(吡啶-2-基)吡啶-2-硫代甲酰胺 |
39122-38-8 |
詳細(xì)
|
| NSC?191412 |
NSC-191412;NSC191412 |
370-16-1 |
詳細(xì)
|
| NSC 207895 |
4-(4-甲基-1-哌嗪基)-7-硝基-2,1,3-苯并二唑 3-氧化物 |
58131-57-0 |
詳細(xì)
|
| NSC23005 Sodium |
NSC 23005鈉鹽 |
1796596-46-7 |
詳細(xì)
|
| NSC 232003 |
1905453-18-0 |
1905453-18-0 |
詳細(xì)
|
| NSC 23766 |
N6-[2-[[4-(二乙基氨基)-1-甲基丁基]氨基]-6-甲基-4-嘧啶基]-2-甲基-4,6-喹啉二胺 |
733767-34-5 |
詳細(xì)
|
| NSC 23925 |
2-(P-METHOXYPHENYL)-Α-2-PIPERIDYL-4-QUINOLINEMETHANOL DIHYDROCHLORIDE |
858474-14-3 |
詳細(xì)
|
| NSC 305787 |
785718-37-8 |
785718-37-8 |
詳細(xì)
|
| NSC305787 (hydrochloride) |
NSC305787鹽酸鹽 |
53868-26-1 |
詳細(xì)
|
| NSC 31150 |
NSC 31150 |
51244-45-2 |
詳細(xì)
|
| NSC 31152 |
5-[(4-chlorophenyl)methylidene]-1,3-thiazolidine-2,4-dione |
24138-83-8 |
詳細(xì)
|
| NSC 31153 |
5-(2-HYDROXY-BENZYLIDENE)-THIAZOLIDINE-2,4-DIONE |
6325-94-6 |
詳細(xì)
|
| NSC 31205 |
NSC31205;NSC-31205;NSC 31205 |
6320-51-0 |
詳細(xì)
|
| NSC 31206 |
2,4-Thiazolidinedione,5-[(4-hydroxy-3-methoxyphenyl)methylene]- |
24044-50-6 |
詳細(xì)
|
| NSC 41589 |
化合物NSC-41589 |
6310-41-4 |
詳細(xì)
|
| NSC 45586 |
Benzoic acid,5-[2-[4-[2-(2,4-diamino-5-methylphenyl)diazenyl]phenyl]diazenyl]-2-hydroxy-,sodium salt (1:1) |
6300-44-3 |
詳細(xì)
|
| NSC 48107 |
4-CHLORO-N,N-DIISOPROPYLBENZAMIDE |
79606-45-4 |
詳細(xì)
|
| NSC 55655 |
5-[(2-nitrophenyl)methylidene]thiazolidine-2,4-dione |
36140-65-5 |
詳細(xì)
|
| NSC 5844 |
N,N'-雙(7-氯-4-喹啉)-1,2-乙二胺 |
140926-75-6 |
詳細(xì)
|
| NSC 601980 |
化合物 T12259 |
2070018-27-6 |
詳細(xì)
|
| NSC 601980 (analog) |
NSC 601980 |
91757-46-9 |
詳細(xì)
|
| NSC 60339 |
2-氯-N1,N4-雙(4-(4,5-二氫-1H-咪唑-2-基)苯基)對苯二甲酰胺 |
70-09-7 |
詳細(xì)
|
| NSC 617145 |
NSC617145 |
203115-63-3 |
詳細(xì)
|
| NSC 622608 |
3-((Furan-2-ylmethyl)imino]-N,N-dimethyl-3H-1,2,4-dithiazol-5-amine Hydrobromide |
2593254-90-9 |
詳細(xì)
|
| NSC 625987 |
NSC 625987 |
141992-47-4 |
詳細(xì)
|
| NSC 632839 |
NSC632839hydrochloride |
157654-67-6 |
詳細(xì)
|
| NSC 639828 |
NSC 639828 |
134742-26-0 |
詳細(xì)
|
| NSC 663284 |
NSC 663284 |
383907-43-5 |
詳細(xì)
|
| NSC 66811 |
7-(ALPHA-苯胺基芐基)-2-甲基-8-喹啉醇 |
6964-62-1 |
詳細(xì)
|
| NSC 668394 |
NSC668394 |
382605-72-3 |
詳細(xì)
|
| NSC 70220 |
9H-Fluorene,9-[3-(2-nitrophenyl)-2-propen-1-ylidene]- |
4551-00-2 |
詳細(xì)
|
| NSC 703786 |
4-(5-氟-1,3-苯并噻唑-2-基)-2-甲基苯胺 |
260443-89-8 |
詳細(xì)
|
| NSC 745885 |
NSC745885 |
4219-52-7 |
詳細(xì)
|
| NSC 781406 |
1676893-24-5 |
1676893-24-5 |
詳細(xì)
|
| NSC 80538 |
NSC 80538;NSC-80538;NSC80538 |
370-26-3 |
詳細(xì)
|
| NSC 87877 |
NSC-87877 |
56990-57-9 |
詳細(xì)
|
| 8-HYDROXY-7-(6-SULFO-2-NAPHTHYLAZO)-5-QUINOLINESULFONIC ACID DISODIUM SALT |
NSC-87877二鈉鹽 |
56932-43-5 |
詳細(xì)
|
| NSC 95397 |
NSC 95397 |
93718-83-3 |
詳細(xì)
|
| Isovaleric acid |
異戊酸 |
503-74-2 |
詳細(xì)
|
| Ginkgolic acid |
銀杏酸C15:1 |
22910-60-7 |
詳細(xì)
|
| Omeprazole sodium |
奧美拉唑鈉 |
95510-70-6 |
詳細(xì)
|
| NH-3 |
化合物NH-3 |
447415-26-1 |
詳細(xì)
|
| 2-NBDG |
2-(N-7-硝基-2,1,3-苯并惡二唑-4-氨基)-2-脫氧-D-葡萄糖 |
186689-07-6 |
詳細(xì)
|
| NAV-2729 |
2-芐基-3-(4-氯苯基)-5-(4-硝基苯基)吡唑并[1,5-A]嘧啶-7(4H)-酮 |
419547-11-8 |
詳細(xì)
|
| Neratinib |
來那替尼 |
698387-09-6 |
詳細(xì)
|
| Tetradecyltrimethylammonium bromide |
十四烷基三甲基溴化銨 |
1119-97-7 |
詳細(xì)
|
| MRT68921 Dihydrochloride |
化合物MRT68921 DIHYDROCHLORIDE |
2080306-21-2 |
詳細(xì)
|
| ODN 1585 |
化合物 ODN 1585 |
386832-46-8 |
詳細(xì)
|
| Noopept |
N-(1-(苯基乙?；?-L-脯氨酰)甘氨酸乙酯 |
157115-85-0 |
詳細(xì)
|
| Neostigmine bromide |
溴化新斯的明 |
114-80-7 |
詳細(xì)
|
| MRT68921 Hydrochloride |
MRT68921 HCl |
2070014-87-6 |
詳細(xì)
|
| AZD-9291 |
奧希替尼 |
1421373-65-0 |
詳細(xì)
|
| MK-0429 |
化合物 T16085 |
227963-15-7 |
詳細(xì)
|
| Osimertinib mesylate |
奧希替尼甲磺酸鹽 |
1421373-66-1 |
詳細(xì)
|
| MKT-077 |
MKT 077 |
147366-41-4 |
詳細(xì)
|
| NOD-IN-1 |
1-甲苯磺酰-1H-吲哚-2-甲酸乙酯 |
132819-92-2 |
詳細(xì)
|
| Ufiprazole |
奧美拉唑硫醚 |
73590-85-9 |
詳細(xì)
|
| Olopatadine hydrochloride |
鹽酸奧洛他定 |
140462-76-6 |
詳細(xì)
|
| (R)-MLN-4760 |
(R)-MLN-4760 |
305335-29-9 |
詳細(xì)
|
| MP-A08 |
219832-49-2 |
219832-49-2 |
詳細(xì)
|
| NDT 9513727 |
化合物 T24524 |
439571-48-9 |
詳細(xì)
|
| NCRW0005-F05 |
化合物NCRW0005-F05 |
342779-66-2 |
詳細(xì)
|
| Syk-IN-1 |
1,2,4-Triazine-6-carboxamide, 3-[[(1R,2S)-2-aminocyclohexyl]amino]-5-(1H-indol-7-ylamino)- |
1491150-77-6 |
詳細(xì)
|
| TH-263 |
TH263 |
313520-94-4 |
詳細(xì)
|
| Taspoglutide |
他司魯泰 |
275371-94-3 |
詳細(xì)
|
| Syk Inhibitor II |
SYK INHIBITOR II |
726695-51-8 |
詳細(xì)
|
| Taltirelin acetate |
醋酸他替瑞林 |
1549593-23-8 |
詳細(xì)
|
| Tetracaine |
丁卡因 |
94-24-6 |
詳細(xì)
|
| TH-257 |
TH-257 |
2244678-29-1 |
詳細(xì)
|
| Sodium lauryl sulfoacetate |
月桂醇磺基乙酸酯鈉 |
1847-58-1 |
詳細(xì)
|
| Sutimlimab |
蘇替莫單抗 |
2049079-64-1 |
詳細(xì)
|
| HEXADECYL[2-([P-METHOXYBENZYL]-2-PYRIMIDINYLAMINO)ETHYL]DIMETHYL-AMMONIUM BROMIDE |
通佐溴胺 |
553-08-2 |
詳細(xì)
|
| THIOFLAVINE S |
硫磺素 |
1326-12-1 |
詳細(xì)
|
| TC-DAPK 6 |
TC-DAPK 6 |
315694-89-4 |
詳細(xì)
|
| Taltirelin |
他替瑞林 |
103300-74-9 |
詳細(xì)
|
| T56-LIMKi |
T5601640 |
924473-59-6 |
詳細(xì)
|
| Tetracaine hydrochloride |
鹽酸丁卡因 |
136-47-0 |
詳細(xì)
|
| PS-1145 |
PS-1145 |
31898-65-6 |
詳細(xì)
|
| SHP099 free base |
SHP-099游離 |
1801747-42-1 |
詳細(xì)
|
| platycoside E |
桔梗皂苷E |
237068-41-6 |
詳細(xì)
|
| PONCIRIN |
枸橘苷 |
14941-08-3 |
詳細(xì)
|
| Resorcinolnaphthalein |
Resorcinolnaphthalein |
41307-63-5 |
詳細(xì)
|
| SK1-IN-1 |
1218816-71-7 |
1218816-71-7 |
詳細(xì)
|
| POT-4 |
AC-ILE-CYS-VAL-TRP(ME)-GLN-ASP-TRP-GLY-ALA-HIS-ARG-CYS-THR-NH2 |
934461-40-2 |
詳細(xì)
|
| Osimertinib dimesylate |
奧希替尼二甲磺酸鹽 |
2070014-82-1 |
詳細(xì)
|
| SKI-178 |
化合物SKI-178 |
1259484-97-3 |
詳細(xì)
|
| CNX-419 hydrobroMide |
CO-1686氫溴酸鹽 |
1446700-26-0 |
詳細(xì)
|
| Parmodulin 2 |
ML 161 |
423735-93-7 |
詳細(xì)
|
| Sobetirome |
SOBETIROME |
211110-63-3 |
詳細(xì)
|
| Polyinosinic-polycytidylic acid sodium salt |
聚肌苷-聚胞苷酸鈉鹽 |
42424-50-0 |
詳細(xì)
|
| SC-514 |
SC-514 |
354812-17-2 |
詳細(xì)
|
| SHP099 HCl |
6- (4- 氨基- 4- 甲基- 1- 哌啶基) - 3- (2, 3- 二氯苯基) - 2- 吡嗪胺,鹽酸鹽(1:1 ) |
2200214-93-1 |
詳細(xì)
|
| SBP-7455 |
化合物SBP-7455 |
1884222-74-5 |
詳細(xì)
|
| Pinacidil |
吡那地爾一水合物 |
85371-64-8 |
詳細(xì)
|
| Pazopanib |
帕唑帕尼 |
444731-52-6 |
詳細(xì)
|
| Cyclic-di-GMP disodium |
CYCLIC DI-GMP SODIUM |
2222132-40-1 |
詳細(xì)
|
| Pyrintegrin |
Pyrintegrin |
1228445-38-2 |
詳細(xì)
|
| SSAA09E2 |
SSAA09E2 |
883944-52-3 |
詳細(xì)
|
| Protirelin acetate |
醋酸普羅瑞林 |
120876-23-5 |
詳細(xì)
|
| SCH79797 dihydrochloride |
SCH79797 DIHYDROCHLORIDE |
1216720-69-2 |
詳細(xì)
|
| SB-3CT |
SB-3CT |
292605-14-2 |
詳細(xì)
|
| PAR-2 (1-6) amide (mouse, rat) |
SER-LEU-ILE-GLY-ARG-LEU-NH2 |
171436-38-7 |
詳細(xì)
|
| Cyclic-di-GMP diammonium |
CYCLIC-DI-GMP DIAMMONIUM |
609343-82-0 |
詳細(xì)
|
| PZ-128 |
L-Phenylalaninamide, N2-(1-oxohexadecyl)-L-lysyl-L-lysyl-L-seryl-L-arginyl-L-alanyl-L-leucyl- |
371131-16-7 |
詳細(xì)
|
| Primidone |
撲米酮 |
125-33-7 |
詳細(xì)
|
| SK1-I hydrochloride |
化合物 SK1-?I HYDROCHLORIDE |
2366222-05-9 |
詳細(xì)
|
| SR7826 |
化合物 T26224 |
1219728-20-7 |
詳細(xì)
|
| RMC-4550 |
RMC-4550 |
2172651-73-7 |
詳細(xì)
|
| Polygalasaponin XXXI |
瓜子金皂苷XXXI |
79103-90-5 |
詳細(xì)
|
| Rasarfin |
化合物RASARFIN |
674359-73-0 |
詳細(xì)
|
| Solvent Blue 35 |
蘇丹藍(lán)Ⅱ |
17354-14-2 |
詳細(xì)
|
| CO-1686 |
CO1686 |
1374640-70-6 |
詳細(xì)
|
| PU-H54 |
化合物PU-H54 |
1454619-13-6 |
詳細(xì)
|
| RO0270608 |
(S)-2-(2-氯-6-甲基苯甲酰氨基)-3-(4-(2,6-二氯苯甲酰氨基)苯基)丙酸 |
220846-33-3 |
詳細(xì)
|
| SB 505124 |
SB-505124 |
694433-59-5 |
詳細(xì)
|
| Phenformin hydrochloride |
鹽酸苯乙福明 |
834-28-6 |
詳細(xì)
|
| R-10015 |
METHYL 2-(1-(7H-PYRROLO[2,3-D]PYRIMIDIN-4-YL)PIPERIDIN-4-YL)-1H-BENZO[D]IMIDAZOLE-6-CARBOXYLATE |
2097938-51-5 |
詳細(xì)
|
| SR35021 hydrochloride |
N-[2-丁基-3-[4-[3-(丁基氨基)丙氧基]苯甲?；鵠-5-苯并呋喃基]甲磺酰胺鹽酸鹽 |
197431-02-0 |
詳細(xì)
|
| Ro24-7429 |
7-氯-N-甲基-5-(1H-吡咯-2-基)-3H-1,4-苯并二氮雜卓-2-胺 |
139339-45-0 |
詳細(xì)
|
| PAZ-417 |
PAZ 417 |
481629-87-2 |
詳細(xì)
|
| Quetiapine fumarate |
富馬酸喹硫平 |
111974-72-2 |
詳細(xì)
|
| Paliperidone |
帕潘立酮 |
144598-75-4 |
詳細(xì)
|
| SU 5416 |
司馬沙尼 |
204005-46-9 |
詳細(xì)
|
| PHPS1 |
4-[2-[1,5-dihydro-3-(4-nitrophenyl)-5-oxo-1-phenyl-4H-pyrazol-4-ylidene]hydrazinyl]-benzenesulfonic acid sodium salt hydrate |
314291-83-3 |
詳細(xì)
|
| PMX-53 |
PMX 53 |
219639-75-5 |
詳細(xì)
|
| Penfluridol |
五氟利多 |
26864-56-2 |
詳細(xì)
|
| REACTIVE BLUE 2 |
活性藍(lán)2 |
12236-82-7 |
詳細(xì)
|
| PAR-4 Agonist Peptide, amide TFA |
PAR-4 AGONIST PEPTIDE, AMIDE TFA |
1228078-65-6 |
詳細(xì)
|
| Torin 1 |
1-[4-[4-(1-氧代丙基)-1-哌嗪基]-3-(三氟甲基)苯基]-9-(3-喹啉基)苯并[H]-1,6-萘啶-2(1H)-酮 |
1222998-36-8 |
詳細(xì)
|
| tolonidine |
托洛尼定 |
4201-22-3 |
詳細(xì)
|
| TM5007 |
化合物TM5007 |
342595-05-5 |
詳細(xì)
|
| Torkinib |
PP242 |
1092351-67-1 |
詳細(xì)
|
| Thiazolidine-4-carboxylic acid |
噻莫西酸 |
444-27-9 |
詳細(xì)
|
| TRAF-STOP inhibitor 6877002 |
化合物6877002 |
433249-94-6 |
詳細(xì)
|
| TPCA-1 |
5-(4-氟苯基)-2-脲基噻吩-3-甲酰胺 |
507475-17-4 |
詳細(xì)
|
| Tiplaxtinin |
替普沙汀 |
393105-53-8 |
詳細(xì)
|
| TRAP-6 |
凝血酶受體激活肽6 |
141136-83-6 |
詳細(xì)
|
| TETRAMETHYLRHODAMINE METHYL ESTER PERCHLORATE |
四甲基羅丹明甲酯高氯酸鹽 |
115532-50-8 |
詳細(xì)
|
| TR antagonist 1 |
500794-88-7 |
500794-88-7 |
詳細(xì)
|
| TR-14035 |
(ALPHAS)-ALPHA-[(2,6-二氯苯甲酰)氨基]-2',6'-二甲氧基聯(lián)苯-4-丙酸 |
232271-19-1 |
詳細(xì)
|